Introduction
Photic stimulation (PS) is widely used in routine video-EEG and can contribute to the management of patients suspected of having epilepsy. It may aid the diagnosis of epilepsy, support and refute specific epileptic syndromes, help predict the likelihood of seizure recurrence and allow the referring physician to counsel the patient on environmental factors that might provoke photosensitive seizures. Useful information can be provided in two ways, first by provoking epileptiform discharges referred to by convention as photoparoxysmal responses (PPRs) and second, it may trigger epileptic seizures and psychogenic non-epileptic attacks (NEAs). The aim is to gain electrographic data without triggering generalised tonic clonic seizures (GTCSs) because of the associated risks to the patient.
The GMC consent guidance [1] emphasises the need for patients to be properly informed prior to consenting to clinical procedures. Because PS is a common procedure and because it is recommended as part of a standard EEG [2] [3] [4] it is important to quantify as far as is practicable the risks and potential benefits (safety and efficacy) of the EEG and PS in order to inform the patient or their proxy prior to their giving or withholding consent. In this case the main risks are precipitating seizures and the main benefits accrue from diagnostic information. Unfortunately, data from large-scale series about safety and efficacy are sparse. In 20,000 cases collected over eleven years [5] PPRs were reported in 225 cases un-associated with accompanying ''convulsions'' and in a further 25 cases ''convulsions'' were induced by PS. In a more recent retrospective series five cases of myoclonic jerks and one of dizziness and distress from 732 undergoing PS were reported [6] .
The current National Service Evaluation described in this paper was designed to determine the efficacy of PS in producing diagnostically useful data, and provide data on the safety of the procedure from a large, national population of adult and paediatric patients. The participating bodies (Association of Neurological Scientists and British Society for Clinical Neurophysiology) represent professionals providing EEG services in every major department in the UK.
Methods
Eighty three departments were invited to participate in the study (see Appendix A). Sixty eight (82%) departments responded. Questionnaires (see Appendix B) were completed for all adult and paediatric patients attending for routine (not sleep-deprived) EEG between the 1st November and 31st December 2013 inclusive so that there was no selection bias in the questionnaires returned for analysis. Sleep-deprived recordings were not included because sleep deprivation has a facilitating effect on PPRs [7] and can be considered an activation technique in its own right.
Questionnaires were completed by the recording clinical physiologist at the time of the EEG and registered details about each patient, including their referral diagnosis and whether PS was performed. As can be seen from the questionnaire (Appendix B), detailed Information about the PS procedure, the make, model and characteristics of the photic stimulators used was not collected.
Referral diagnoses other than epilepsy or non-epileptic attack disorder (NEAD) such as neurodegenerative diseases could be captured on the questionnaire.
In the case of NEAD, the questionnaire did not record whether or not the referring doctor requested an attempt to elicit a NEA.
If PS was not performed, physiologists were required to specify a reason. Exclusions such as 'too old' were based on local protocols that have been separately surveyed [8] .
Physiologists registered a 'Yes' or 'No' if a PPR (without discernible clinical changes) occurred. The cases with discernible clinical changes associated with PS were classified by the physiologist at the time of the video-EEG as either a seizure or a NEA. For the purposes of the study, we broadly defined seizures as clinical neurological events with an EEG correlate, even if brief (e.g. myoclonic jerks). These were subsequently further subdivided as far as was practicable into seizure types. NEAs were not subdivided into semiological categories.
With regard to electrographic events produced by PS, the questionnaire was designed to identify specified electrographic changes i.e. ''unequivocal generalised epileptiform interictal EEG activity (i.e. a Type III or IV photoparoxysmal response) NOT seen in the resting record.'' All references to a PPR in this paper describe instances of Waltz et al. [9] Type III/IV. The higher grade response, particularly grade IV, is associated with a greater tendency towards seizures [10] [11] [12] .
Information on the specific PS protocol was not collected. The data were analysed using Microsoft Access and Excel and IBM SPSS version 19.
Ethical approval is not a requirement for the service evaluation of routine clinical practice (UK NHS National Research Ethics Service guidelines), nevertheless the project was registered as a service evaluation with Sheffield Teaching Hospitals NHS Trust Clinical Effectiveness Unit.
Results

Demographics of those that did or did not undergo PS
PS was included in the EEG examination of 5383 patients (79%) from a total of 6807 undergoing routine EEG. The 5383 patients that underwent PS included 2061 children (17 years of age). In the 1277 patients for whom a reason for excluding PS was provided, the most commonly given reasons were: the patient was ''too old'' in 290 (23%), showed ''insufficient cooperation'' in 235 (18%), was ''too young'' in 120 (9%) and ''patient refused'' in 84 (7%). Those who did not undergo PS were older than those who did and PS was performed more frequently in patients referred with epilepsy and/or NEAD than for other diagnoses (Figs. 1 and 2; Table 1 ).
Efficacy: Evoking PPRs
A PPR occurred in the EEGs of 79 of 5383 cases that underwent PS (1.5%), being the first instance of an interictal epileptiform EEG feature in the terms defined by the project protocol. The referral diagnosis in cases whose EEGs contained PPRs was epilepsy in 75 cases, NEAD in 2 cases, epilepsy plus NEAD in 1 case and 'other' in 1 case. 
Efficacy: Seizures
In 39 cases (0.7%) seizures occurred in association with PS. The seizure type in 36 (92.3%) was ''generalised'' and it was ''focal'' in the remaining 3 (7.7%). The 36 cases with ''generalised'' seizures were further classified as myoclonus (17), absences (11), eyelid myoclonia (3), GTCS (2), myoclonic absence (1), atonic (1), eyelid flicker without loss of awareness (1) . One focal seizure was described as ''focal myoclonus'' while the other two patients' seizures were described as ''focal myoclonus/spasm''.
In 16 (41%) of the 39 cases, a seizure had been noted as occurring in the resting or hyperventilation parts of the record by the physiologist (Fig. 4) . In 23 of the 39 cases (59%) no seizure had been observed by the physiologist prior to PS. Consequently, PS more than doubled the tally of seizures that could be recorded.
Efficacy: Non-epileptic attacks
Forty nine patients (0.9%) had NEAs triggered by PS. In 29 of these 49 cases, the patient was referred with suspected NEAD. In 13 of these 29 cases (45%) there had already been a NEA prior to PS (Fig. 4) . But in the remaining 16 cases (55%) PS was effective in eliciting a properly witnessed and recorded attack that would otherwise not have been seen.
Efficacy: Age
The relationship between age and the incidence of seizures, PPRs and NEAs is illustrated in Fig. 3 . The age range of cases with seizures was between 2 and 67 years (mean 17 years; median 13 years). The age range of cases with NEAs was between 9 and 71 years (mean 35 years; median 32 years). The age range of cases with PPRs was between 1 and 65 years, (mean 19 years; median 15 years).
Efficacy: AED use
A minority, 1353, (25%) of the 5383 cases were medicated with AEDs. PPRs without a seizure occurred in 18 medicated cases (1.3%) and PPRs associated with a seizure occurred in the remaining 10 cases (0.7%). The majority, 4030, (75%) of cases were not medicated with AEDs. PPRs without a seizure occurred in 61 unmedicated cases (1.5%) and PPRs occurred with a seizure in the remaining 29 un-medicated cases (0.7%).
The data in the above paragraph suggest that medication has not influenced the occurrence of PPRs or seizures within the limitations of this study sample. Chi-squared test shows that there is no relationship between whether the patient is taking AEDs and whether they had a PPR (p = 0.628) or a seizure (p = 0.942).
Efficacy: Overall
In 167 (3.1%) cases PS elicited a PPR or a seizure or a nonepileptic attack. In 122 cases (2.3%), PS contributed the definitive information to support a diagnosis of epilepsy or NEAD (Fig. 4) . The 122 cases include 72 with a PPR (no seizure during PS), and 50 with a seizure or NEA elicited by PS, in which there had been no attack in the preceding resting or hyperventilation EEG. In the remaining 45 cases (Fig. 4) there had already been a clinical attack prior to PS; in this eventuality, the outcome of the EEG was likely to have been decisive without employing PS.
Safety: GTCSs provoked by PS
GTCS occurred in 2 cases (0.04%) out of the 5383 cases in the study i.e. 1:2692 cases. The patients were a female aged 13 years and a male aged 25 year; both were taking AEDs. Both GTCSs resolved spontaneously and neither patient required admission to the ward.
Discussion
The purpose of this study was to provide evidence on the safety and efficacy of photic stimulation in routine clinical practice, based on data collected prospectively from a large number of clinical neurophysiology departments. The main risk (that was to be quantified) was epileptic seizures, particularly GTCSs. The potential benefit of PS was expected to arise from improved diagnostic precision.
PPRs
In the current study, 79 cases (1.5%) developed a PPR without a seizure (Fig. 4) . This is similar to the findings of Wadlington and Riley [5] . Of their 20,000 cases, 225 (1.1%) developed PPRs. (It should be noted that in the current study, PPRs were only reported if the preceding parts of EEG had been free of inter-ictal epileptiform discharges, to avoid interpretative confusion). In a study of 1000 cases from a tertiary referral centre, 732 of which underwent PS, 16 (2.2%) exhibited Type IV (Waltz et al.) changes in the EEG; 11 had inter-ictal epileptiform discharges in the previous parts of the EEG [6] .
In a study that included 1267 cases undergoing PS, ''Epileptiform responses'' were reported in 42 (3.3%) [21] .
Seizures
In the current study, 39 cases (0.7%) had a seizure triggered by PS, but there were only 2 cases (0.04%) of GTCSs evoked during PS. In the series published by Wadlington and Riley [5] , the seizure type induced by PS is only stated for a small number of illustrative cases. However, based on these authors' terminology of 'overt convulsions', the seizure type is likely to have been GTCS in the majority of instances, with an overall incidence of 0.13% (from an inspection of the sample of case reports that were published). The higher incidence in their study is likely to reflect differing, arguably less constrained, stimulus protocols. No cases of GTCS occurred in the 732 reported by Angus-Leppan [6] , probably because of the small sample size.
NEAs
NICE guidelines (CG 137, 2012) do not recommend the use of EEG to exclude a diagnosis of epilepsy if the clinical presentation points to NEAD (1.6.7). However, the presenting diagnosis of NEAD may be a partial picture as in the four cases in this series referred with a diagnosis of NEAD (Table 2) in which there was a PPR during PS.
NICE guidelines also mention that 'provocation by suggestion' [such as in association with PS] may lead to false-positive conclusions. This risk can be minimised if the attacks and concurrent EEG are accompanied by high quality video and remontaged to improve identification of artefact. With these provisos, PS can usefully enhance the diagnostic potential of the EEG. The SIGN epilepsy guideline supports this and advises the use of suggestion for the diagnosis of suspected NEAD (143) [20] .
In this series, PS was able to support the proffered diagnosis of NEAD in 29 of 391 referrals (7.4%) who had a NEA during PS. In 16 of these 29 patients (4% of the 391 referrals), this was the only attack captured (with none having previously occurred in the resting or hyperventilation parts of the record). In addition, 17 patients in this series who were referred with a diagnosis of epilepsy had a NEA during PS (Table 2) .
Previous studies [13, 14] focussed on PS, HV and ''suggestion'' in combination for evoking NEAs (yield 67-84%). Neither of these papers differentiated the yield from PS alone. The present study, together with the recent paper by the National Audit Group on HV [15] , helps to distinguish the effectiveness of these two provocation techniques individually in relation to NEAs. The yield for the two procedures analysed separately, in two different case populations, has turned out to be 0.9% in both Kane et al.'s and this study.
Age
In the current study, the median age at which seizures and PPRs occurred was 13 and 15 years respectively; for PPRs this is slightly higher than the 12 years of age for PPRs reported by Harding and Jeavons [16] . Twenty cases (4.4%) from the above mentioned authors had PPRs persisting above the age of 30 years, a finding echoed in this study.
PS was omitted because patients were 'too old' from their 5th decade onwards. However, the oldest patient having a NEA was 71 years old highlighting potential missed opportunities to capture NEAs.
AEDs
AEDs have been reported to reduce the occurrence of PPRs. Harding et al. [17] found that PPRs were abolished by AEDs in 27 of 50 photosensitive subjects, with an attenuation of sensitivity in a further 12. However, no effect of AEDs on the incidence of a PPR or seizures was apparent in the current study. This finding should be interpreted with caution, primarily because the two study groups had different selection criteria. The Harding study specifically included cases of known sensitivity to xenon flash, whereas the current study is from an unselected cohort.
Constraints
In the current study PPRs were only documented when no epileptiform discharges had occurred in the EEG prior to PS. This allows us to comment robustly on the extra diagnostic information obtained from performing PS, but we have, through this constraint, probably missed describing some instances where the presence of a PPR might have helped in epilepsy classification, elucidation of an epileptic syndrome, and perhaps the ability to counsel the patient regarding safety. Therefore, the estimate in this study of the usefulness of PS in EEG is likely to be a slight under-estimate.
Recording detailed information about captured NEAs was beyond the scope of the present study and is the subject of an on-going national service evaluation. Information on the PS protocol used was not collected, so the effect of protocol variation on the diagnostic yield from PS [18] cannot be ascertained. This is a domain with many variables and no comprehensive scientific evidence base. A related study has shown that UK practice is varied [8] , leading to the recent formulation of ANS-BSCN national standards [19] . Expert groups have rationalised the process of photic stimulation in clinical practice, but they have been unable to arrive at a consensus for every detail of the procedure (Harding personal communication). Consequently variation in practice is not unexpected even though it may need justification. The phasing out of xenon discharge tubes in favour of LED stimulators was completely uncontrolled and is an example of the difficulties of rationalizing practice.
Conclusion
Photic stimulation elicited useful diagnostic findings in 3.1% of cases; in 2.3% cases this was the only part of the EEG process that elicited diagnostically helpful information.
The risk of inducing a GTCS was 0.04% (1 in 2692) i.e. the seizure type most likely to be associated with clinical harm to the patient. The need for the procedure to be carried out in a properly controlled environment is self evident.
All seizures may have implications for employment, driving and the patient's confidence and dignity, emphasising the need for properly informed and monitored continuing consent.
We conclude that the study has provided reliable data to inform the consent process for this valuable procedure. Patients can use the data from this study to decide whether the risk vs. benefit ratio is acceptable.
Conflict of interest statement
None.
